132672-22-1

Upstream product

• 1761-61-1 5-bromosalicyclaldehyde 
• 136058-85-0 2-(5-Methyl-2-m-tolyl-oxazol-4-ylmethyl)-benzofuran-5-carbonitrile 
• 136058-78-1 (5-Bromo-benzofuran-2-yl)-(5-methyl-2-m-tolyl-oxazol-4-yl)-methanol 
• 136058-75-8 (5-Bromo-benzofuran-2-yl)-(5-methyl-2-m-tolyl-oxazol-4-yl)-methanone 
• 136058-81-6 4-(5-Bromo-benzofuran-2-ylmethyl)-5-methyl-2-m-tolyl-oxazole 
• 132646-35-6 2-<<5-methyl-2-(3-methylphenyl)-4-oxazolyl>methyl>benzofuran-5-carboxaldehyde 

Relevant academic research and scientific papers

Benzyloxazolidine-2,4-diones as potent hypoglycemic agents

A series of benzyloxazolidine-2,4-diones, containing oxazole-based side chains, were found to lower blood glucose levels in the genetically obese ob/ob mouse. Incorporation of a benzofuran structural element in these compounds provides greatly enhanced in vivo potency. The syntheses and structure-activity relationships for this series are detailed.